Avania Revenue and Competitors
Estimated Revenue & Valuation
- Avania's estimated annual revenue is currently $35M per year.
- Avania's estimated revenue per employee is $110,759
Employee Data
- Avania has 316 Employees.
- Avania grew their employee count by 9% last year.
Avania Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 25 | 67% | N/A | N/A |
#2 | $35M | 316 | 9% | N/A | N/A |
What Is Avania?
Avania brings knowledgeable experts together to form a unique CRO that advances the research of medical devices, novel technology, and combination products across a wide range of therapeutic specialties. Our motivated team takes you from feasibility all the way through post-market trials. Our experts in data management and analytics, clinical trial design & execution, strategic consulting, regulatory, reimbursement, and more will provide you with customized, scalable solutions that optimize efficiencies and streamline the advancement of your medical technology. Your product is important, and your company deserves the team that has what it takes. It takes knowledge. It takes passion. It takes commitment. It takes Avania.
keywords:N/A
N/A
Total Funding
316
Number of Employees
$35M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avania's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Principal Consultant | Reveal Email/Phone |
2 | Executive Director Business Development (US) | Reveal Email/Phone |
3 | Talent Acquisition Partner | Reveal Email/Phone |
4 | Biostatistician II | Reveal Email/Phone |
5 | Clinical Project Manager | Reveal Email/Phone |
6 | IT Manager | Reveal Email/Phone |
7 | Project Manager | Reveal Email/Phone |
8 | Director, Clinical Operations | Reveal Email/Phone |
9 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
10 | Financial Analyst | Reveal Email/Phone |
Avania News
BILTHOVEN, Netherlands--(BUSINESS WIRE)--Feb 26, 2021-- Avania, a leading global full-service contract research organization (CRO) focused on medical technology (MedTech) development, today announced that it has successfully refinanced its existing banking facilities with Crescent Capital Group ...